In a series of special reports, Drug Store News looks at some of the top trends impacting pharmacy in this pivotal year for the nation’s health system.
Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker.
Remedies for conditions like hepatitis C, NASH (nonalcoholic steatohepatitis) and oncology will all help contribute to growth within the biotech sector, according to an analysis from Bloomberg Intelligence.
Nine-in-10 consumers who opted for a needle-free flu shot this season would choose that option again and recommend it to family and friends.
ACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot.
Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.
The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.
A team of researchers at Columbia Engineering has developed a low-cost smartphone accessory that can perform a point-of-care test for HIV or syphilis in just 15 minutes.
A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."
Sharecare on Thursday launched an app that monitors voice inflection as a tool toward better health.